Mr. Johnson indicated that he thought they were still going to face some problems weaning consumers off coupons, promotions, and low-lower-lowest price strategies.
But the allegations undermine a premise regularly offered by the pharmaceutical industry that the numerous settlements concerning off-label promotions and kickbacks reflect years-old business practices that have since been transformed.